Back to search results

Person

Dr. G. Huls

Pagina-navigatie:

Update Persondata

Grants/prizes	NWO-Veni 2006-2

Active as

Researcher
Organisation	Department of Internal Medicine (RUG)
Email	g. huls -at- int. umcg. nl

Current research

(the most recent research is at the top)
Project leader	Randomized maintenance therapy with Azacitidine (Vidaza) in older patients (>60 years of age) with acute myeloid leukemia (AML) and refractory anemia with excess of blasts (RAEB, RAEB-t) (HOVON 97 AML study)
Project leader	The involvement of NPM mutations and E-Cadherin in the development of AML

Completed research projects

(the most recent research is at the top)
Project leader	High dose Simvastatin combined with palliative chemotherapy (Hydrea or 6-Mercaptopurine) in patients with (relapse) acute myeloid leukemia not eligible for high dose chemotherapy. A phase II study.
Project leader	High dose Simvastatin combined with standard chemotherapy (Daunorubicin and Cytarabin) in patients with relapse acute myeloid leukemia younger than 65 years. A phase II study.

Classification

D23120	Oncology
D23221	Blood and lymphatic diseases

Go to page top
Go back to contents
Go back to site navigation